(Q46115635)

19 December 2017

title

Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study (English)

1 reference

19 December 2017

1 reference

3

1 reference

19 December 2017

Peter D Siersema

27

object named as

P D Siersema

1 reference

19 December 2017

author name string

M Sikkema

1

1 reference

19 December 2017

C W N Looman

2

1 reference

19 December 2017

M Kerkhof

4

1 reference

19 December 2017

F Kastelein

5

1 reference

19 December 2017

H van Dekken

6

1 reference

19 December 2017

A J van Vuuren

7

1 reference

19 December 2017

W A Bode

8

1 reference

19 December 2017

H van der Valk

9

1 reference

19 December 2017

R J T Ouwendijk

10

1 reference

19 December 2017

R Giard

11

1 reference

19 December 2017

W Lesterhuis

12

1 reference

19 December 2017

R Heinhuis

13

1 reference

19 December 2017

E C Klinkenberg

14

1 reference

19 December 2017

G A Meijer

15

1 reference

19 December 2017

F ter Borg

16

1 reference

19 December 2017

J W Arends

17

1 reference

19 December 2017

J J Kolkman

18

1 reference

19 December 2017

J van Baarlen

19

1 reference

19 December 2017

R A de Vries

20

1 reference

19 December 2017

A H Mulder

21

1 reference

19 December 2017

A J P van Tilburg

22

1 reference

19 December 2017

G J A Offerhaus

23

1 reference

19 December 2017

F J W ten Kate

24

1 reference

19 December 2017

J G Kusters

25

1 reference

19 December 2017

E J Kuipers

26

1 reference

19 December 2017

language of work or name

English

0 references

publication date

17 May 2011

1 reference

19 December 2017

The American Journal of Gastroenterology

published in

1 reference

19 December 2017

volume

106

1 reference

19 December 2017

issue

7

1 reference

19 December 2017

page(s)

1231-1238

1 reference

19 December 2017

Barrett's esophagus, dysplasia, and adenocarcinoma

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Mechanisms of disease: Carcinogenesis in Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Increasing incidence of Barrett's oesophagus in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Risk Factors for the Development of Esophageal Adenocarcinoma in Barrett's Esophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Low-grade dysplasia in Barrett's esophagus has a high risk of progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Length of Barrett's oesophagus: an important factor in the development of dysplasia and adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Risk factors for dysplasia in patients with Barrett's esophagus (BE): results from a multicenter consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

The Vienna classification of gastrointestinal epithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Relaxing the rule of ten events per variable in logistic and Cox regression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Internal validation of predictive models: efficiency of some procedures for logistic regression analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Risk factors for Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Routinely diagnosed low-grade dysplasia in Barrett's oesophagus: a population-based study of natural history.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Aneuploidy and Overexpression of Ki67 and p53 as Markers for Neoplastic Progression in Barrett's Esophagus: A Case–Control Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Clinical decision making in Barrett's oesophagus can be supported by computerized immunoquantitation and morphometry of features associated with proliferation and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

The role of quantitative pathology in clinical decision making for Barrett's oesophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Predictors of progression in Barrett's esophagus: current knowledge and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Barrett's oesophagus is characterized by a predominantly humoral inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

Symptomatic Gastroesophageal Reflux as a Risk Factor for Esophageal Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.153

21 January 2018

Identifiers

DOI

10.1038/AJG.2011.153

1 reference

19 December 2017

1 reference

19 December 2017